Oral BPaLM regimen is noninferior to standard of care for rifampin-resistant tuberculosis
1. A 24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) resulted in lower mortality, treatment failure, and discontinuation compared ...